As cancer diagnosis becomes increasingly digital, tools like CGS-Net promise to enhance, and not replace, human expertise. By teaching machines to see as doctors do, UMaine researchers are helping ...

Estimating the cell type composition in a tissue sample using bulk data is a major challenge in cancer research. To address this, researchers at Oregon Health & Science University (OHSU) have ...

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...

In a significant step towards advancing early cancer detection in India, Strand Life Sciences, a subsidiary of Reliance ...

For more than a century, tissue biopsies have stood as the gold standard for diagnosing cancer. And for good reason. These ...

Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...

Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...